Published in Environ Health on February 22, 2007
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol (2009) 1.64
Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med (2008) 1.00
Environmental exposures, epigenetic changes and the risk of lupus. Lupus (2014) 0.99
Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol (2013) 0.86
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus. J Immunol (2013) 0.85
Pesticides, chemical and industrial exposures in relation to systemic lupus erythematosus. Lupus (2014) 0.84
Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice. Mediators Inflamm (2010) 0.84
Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model. Clin Exp Immunol (2014) 0.83
Mercury alters B-cell protein phosphorylation profiles. J Proteome Res (2013) 0.80
Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritis. JRSM Short Rep (2011) 0.78
Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice. BMC Immunol (2015) 0.77
The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol (2016) 0.77
Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol (2013) 0.77
Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study. Arthritis Rheumatol (2014) 0.76
TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus. J Immunol (2016) 0.76
Mercury in Hair Is Inversely Related to Disease Associated Damage in Systemic Lupus Erythematosus. Int J Environ Res Public Health (2015) 0.75
Pristane-induced lupus: considerations on this experimental model. Clin Rheumatol (2017) 0.75
Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells. Toxicol Appl Pharmacol (2017) 0.75
Effect of dietary pristane and other saturated mineral oils (MOSH) on autoimmune arthritis in rats. Toxicol Rep (2017) 0.75
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus. PLoS One (2017) 0.75
Hazardous waste and health impact: a systematic review of the scientific literature. Environ Health (2017) 0.75
Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med (1974) 3.33
Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med (1994) 2.02
Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum (1999) 1.87
Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med (1998) 1.85
The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum (1973) 1.76
Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol (1981) 1.63
Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc (1985) 1.59
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A (1995) 1.56
The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med (1967) 1.45
Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol (2003) 1.44
Analysis and stability of mercury speciation in petroleum hydrocarbons. Fresenius J Anal Chem (2000) 1.41
Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol (2004) 1.31
The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo. J Exp Med (1976) 1.27
Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum (1971) 1.20
Induction of lupus autoantibodies by adjuvants. J Autoimmun (2003) 1.18
Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol (2000) 1.15
Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol (1996) 1.15
Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin Immunol Immunopathol (1993) 1.13
Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res (1999) 1.06
Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol (1998) 1.05
Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect (2003) 1.05
Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect (1999) 1.05
Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect (1999) 1.04
Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother (2004) 1.02
Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol (1995) 1.00
Occupational acroosteolysis. Arch Dermatol (1972) 0.98
Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol Appl Pharmacol (1992) 0.97
Autoimmunity and heavy metals. Lupus (1994) 0.95
Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clin Exp Immunol (1999) 0.95
Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med (2003) 0.94
Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. J Immunol Methods (1995) 0.93
Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol (2001) 0.93
Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol (1989) 0.91
Epidemiology of systemic lupus erythematosus. Ann Rheum Dis (1992) 0.90
Health effects on nearby residents of a wood treatment plant. Environ Res (2003) 0.89
Aromatic amines and the pathogenesis of lupus erythematosus. Am J Med (1983) 0.87
Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction. Eur J Immunol (2000) 0.87
Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB J (1994) 0.85
Medication-induced systemic lupus erythematosus. Clin Ther (1992) 0.84
Immunoregulation and anti-nuclear antibodies in mercury-induced glomerulopathy in the rat. Clin Exp Immunol (1981) 0.84
Expression of mammalian 60-kD heat shock protein in the joints of mice with pristane-induced arthritis. Clin Exp Immunol (1996) 0.84
Minor effects of low exposure to inorganic mercury on the human immune system. Scand J Work Environ Health (1993) 0.83
Experimental studies on genetically determined susceptibility to mercury-induced autoimmune response. Ren Fail (1999) 0.83
Autoimmunity and selected environmental factors of disease induction. Semin Arthritis Rheum (1993) 0.82
Pristane-induced arthritis in mice. V. Susceptibility to pristane-induced arthritis is determined by the genetic regulation of the T cell repertoire. Arthritis Rheum (1998) 0.81
Pristane-induced arthritis is CD4+ T-cell dependent. Immunology (1997) 0.81
Contact stomatitis to mercury associated with spontaneous mononuclear cell infiltrates in brown Norway (BN) rats with HgCl2-induced autoimmunity. J Oral Pathol Med (1994) 0.80
Induction of B cell autoimmunity by pristane. Curr Top Microbiol Immunol (1999) 0.80
Systemic lupus erythematosus in relation to environmental pollution: an investigation in an African-American community in North Georgia. Arch Environ Health (1997) 0.80
Mercury-induced autoimmune glomerulonephritis in inbred rats. I. Kinetics and species specificity of autoimmune responses. Surv Synth Pathol Res (1985) 0.80
Experimental mercury-induced glomerulonephritis. Springer Semin Immunopathol (1987) 0.80
Calcium hypochlorite removal of mercury and petroleum hydrocarbons from co-contaminated soils. Waste Manag Res (2002) 0.79
Effects of occupational exposure to mercury vapor on lymphocyte micronuclei. Scand J Work Environ Health (1991) 0.79
IL-2 may be a limiting factor precluding lymphocytes from genetically resistant mice from responding to HgCl2. Int Immunol (1999) 0.78
Estimate of mercury emissions to the atmosphere from petroleum. Environ Sci Technol (2001) 0.78
Strain differences in the effect of mercury on murine cell-mediated immune reactions. Food Chem Toxicol (1991) 0.78
Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas. Curr Top Microbiol Immunol (2000) 0.78
Immunoglobulin levels in workers exposed to inorganic mercury. Pharmacol Toxicol (1994) 0.78
Thiol compounds inhibit mercury-induced immunological and immunopathological alterations in susceptible mice. Clin Exp Immunol (1997) 0.77
Minimal immunological effects on workers with prolonged low exposure to inorganic mercury. Occup Environ Med (1997) 0.77
Occupational acroosteolysis. 3. A clinical study. Arch Environ Health (1971) 0.77
B cell subsets in pristane-induced autoimmunity. Curr Top Microbiol Immunol (2000) 0.76
Activated human T lymphocytes exhibit reduced susceptibility to methylmercury chloride-induced apoptosis. Toxicol Sci (1999) 0.76
Inhibition of pristane-induced peritoneal plasmacytoma formation. Curr Top Microbiol Immunol (1999) 0.76
Environmental personal injury litigation as one source of response effects: findings from the National Exposure Registry. Toxicol Ind Health (1996) 0.76
Immune system alteration in the rat after indirect exposure to methyl mercury chloride or methyl mercury sulfide. Environ Res (1997) 0.76
The in vitro effects of mercury on peritoneal leukocytes (PMN and macrophages) from inbred brown Norway and Lewis rats. Int J Immunopharmacol (1992) 0.76
Ecotropic murine leukemia viruses and exogenous mouse mammary tumor viruses are not essential for pristane-induced lupus. Arthritis Rheum (2003) 0.76
Immune dysregulation and auto-immunity induced by toxic agents. Transplant Proc (1982) 0.75
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (2005) 5.43
HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis (2008) 2.44
Frequency of nurses' smoking cessation interventions: report from a national survey. J Clin Nurs (2009) 2.15
Validation of serum biomarkers for detection of early-stage ovarian cancer. Am J Obstet Gynecol (2009) 1.90
Assessing nursing staffing ratios: variability in workload intensity. Policy Polit Nurs Pract (2007) 1.57
Residential and biological exposure assessment of chemicals from a wood treatment plant. Chemosphere (2007) 1.46
Persistent organic pollutants in 9/11 world trade center rescue workers: reduction following detoxification. Chemosphere (2007) 1.43
Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med (2012) 1.23
Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer (2009) 1.23
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention. AIDS Patient Care STDS (2009) 1.20
Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health (2004) 1.20
Animal-assisted therapy in patients hospitalized with heart failure. Am J Crit Care (2007) 1.12
Initiating HIV care: attitudes and perceptions of HIV positive crack cocaine users. AIDS Behav (2007) 1.07
An alternative approach to reducing the costs of patient care? A controlled trial of the multi-disciplinary doctor-nurse practitioner (MDNP) model. Med Decis Making (2006) 1.05
Test-retest reliability of a complex human immunodeficiency virus research questionnaire administered by an Audio Computer-assisted Self-interviewing system. Med Care (2003) 1.02
Symptom severity 1 to 4 months after thoracotomy for lung cancer. Am J Crit Care (2008) 1.02
Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS). AIDS Patient Care STDS (2007) 1.01
Rodent allergen in Los Angeles inner city homes of children with asthma. J Urban Health (2007) 0.90
Health effects on nearby residents of a wood treatment plant. Environ Res (2003) 0.89
Strawberry consumption is associated with increased antioxidant capacity in serum. J Med Food (2010) 0.89
Sexual intercourse and oral sex among public middle school students: prevalence and correlates. Perspect Sex Reprod Health (2010) 0.85
Diffusing capacity and forced vital capacity in 5,003 asbestos-exposed workers: relationships to interstitial fibrosis (ILO profusion score) and pleural thickening. Am J Ind Med (2013) 0.85
Self-reported health effects among community residents exposed to perfluorooctanoate. New Solut (2008) 0.84
Acute painful stress and inflammatory mediator production. Neuroimmunomodulation (2013) 0.84
Exposure assessment of residents living near a wood treatment plant. Environ Res (2003) 0.83
Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. Am J Obstet Gynecol (2009) 0.83
Nurses trying to quit smoking using the Internet. Nurs Outlook (2009) 0.82
Do you need to smoke to get a break?: smoking status and missed work breaks among staff nurses. Am J Prev Med (2009) 0.82
System and patient barriers to appropriate HIV care for disadvantaged populations: the HIV medical care provider perspective. J Assoc Nurses AIDS Care (2006) 0.81
Health-related quality of life and patient reports about care outcomes in a multidisciplinary hospital intervention. Ann Behav Med (2006) 0.81
Value-added care: a new way of assessing nursing staffing ratios and workload variability. J Nurs Adm (2007) 0.79
Increasing nursing referral to telephone quitlines for smoking cessation using a web-based program. Nurs Res (2012) 0.76
Smoking among psychiatric nurses: does it hinder tobacco dependence treatment? J Am Psychiatr Nurses Assoc (2009) 0.75
Nurses' treatment of tobacco dependence in hospitalized smokers in three states. Res Nurs Health (2012) 0.75
Value-added care: a paradigm shift in patient care delivery. Nurs Econ (2008) 0.75